Indivior (LON:INDV) Given New GBX 1,500 Price Target at Deutsche Bank Aktiengesellschaft

Indivior (LON:INDV) had its target price cut by Deutsche Bank Aktiengesellschaft from GBX 2,350 ($30.10) to GBX 1,500 ($19.21) in a report released on Tuesday, Marketbeat.com reports. They currently have a buy rating on the specialty pharmaceutical company’s stock.

Indivior Stock Down 3.4 %

LON:INDV opened at GBX 814.50 ($10.43) on Tuesday. The firm has a market capitalization of £1.10 billion, a PE ratio of 27,150.00, a price-to-earnings-growth ratio of -5.57 and a beta of 0.06. The stock has a 50 day moving average of GBX 1,286.32 and a 200-day moving average of GBX 1,409.42. Indivior has a 52 week low of GBX 653 ($8.36) and a 52 week high of GBX 1,938 ($24.82). The company has a current ratio of 0.93, a quick ratio of 1.52 and a debt-to-equity ratio of 2,790.00.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.